ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDEN Eden Research Plc

4.25
-0.10 (-2.30%)
Last Updated: 09:58:33
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -2.30% 4.25 4.00 4.50 4.35 4.25 4.35 190,459 09:58:33
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -11.90 26.67M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.35p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £26.67 million. Eden Research has a price to earnings ratio (PE ratio) of -11.90.

Eden Research Share Discussion Threads

Showing 17726 to 17744 of 17925 messages
Chat Pages: 717  716  715  714  713  712  711  710  709  708  707  706  Older
DateSubjectAuthorDiscuss
11/4/2024
01:58
@supersonico
Hey monkey, if you want to invest in Sipcam, do so. It isn't the Eden dawg. Can't you grasp even the simplest concepts, or are you doomed to remain a fuxxtard forever, like Timbo_Slice

neutralpov
10/4/2024
18:58
The team at Sipcam Agro Solutions LLC, located in Waynesboro, MS, is excited to launch our new LinkedIn company page! If you follow Sipcam Agro USA, you know of the December 2024 acquisition of Waynesboro, Mississippi-based Odom Industries assets including plants with formulation, packaging and warehousing. Sipcam Agro Solutions, LLC, was formed and many improvements have been made and there are many more to come. What these combined facilities of over 320,000 square feet of production and warehousing capability on 40 acres does for Sipcam Agro USA is allow Sipcam Agro USA to consolidate their presence in the U.S. agrochemical, biostimulants and biorationals markets. This major investment in new solutions for Crop Protection and Turf and Ornamental (T&O) markets will enable Sipcam Agro USA to deliver new products to the market through domestic formulation and packaging capabilities.

Check back for more great news coming out of Mississippi and the growth of Sipcam Agro Solutions!

supersonico
10/4/2024
16:13
Looking ahead ..will Euroseeds2024 see the PR from Corteva / Eden of Sunflower seed with EUA in Italy to follow as we move towards full approval?
supersonico
10/4/2024
15:18
It appears to me that Promising Jam tomorrow is the way the AIM cottage industry works... the art is not passing into the next realm before the sweet trolley pulls up , accumulating wisely in a timely fashion until in Eden's case Smith puts Syngenta in an RNS and the Jam arrives.
supersonico
10/4/2024
14:25
I realise but the promising of jam tomorrow is embarrassing, have they not learnt anything over the 15 years of promising...I think the directors are gravy train occupants
bjlk
10/4/2024
12:47
supersonico 10 Apr '24 - 10:48 - 17342
> Come on Mr Smith just get on with it and put 'Syngenta' in an RNS.

Move to Scotland - their institutions for the clinically insane are better.

neutralpov
10/4/2024
10:48
Come on Mr Smith just get on with it and put 'Syngenta' in an RNS.
supersonico
10/4/2024
10:46
Flith? - cause I disagree with your point of view.
kittybiscuits
09/4/2024
17:13
Nor should you - you don't even own any shares. Muppet.
kittybiscuits
09/4/2024
14:08
Alchemy, take a cognitive impairment test. You really should NOT be here.

:D

neutralpov
09/4/2024
13:52
Not chastise the slow purchasers ? They know the offer. Or the regulators ? Sales is not just an energy occupation .
alchemy
09/4/2024
13:36
I believe in the products but I believe the management should be strung up for the snails pace sales... gravy boating in the extreme....
bjlk
09/4/2024
11:39
Mr Smith already knows.

3LOGY is the innovative fungicide for the control of vines.
The product has an exclusive SUSTAINE formulation that allows the modulated release of the 3 active principles, in the presence of conditions favouring the development of the disease. 3LOGY Check the barrels from flowering to pre-harvest.

supersonico
08/4/2024
20:05
SustainE ??
supersonico
08/4/2024
16:45
More a statement of fact than an assertion.
timbo_slice
08/4/2024
10:51
And not single shred of factual evidence in there. I think any investor here only needs to look at your own posting history to see you are bitter, twisted and revengeful fool who is either (a) investor who lost a wedge or (b) an ex employee!
kittybiscuits
08/4/2024
08:46
WARNING TO POTENTIAL ""INVESTORS"" (sic) IN THIS COMPANY WHOSE DIRECTORS SHUN ITS OWN SHARES!!

But the one paid ramper (with a bewildering multitude of fake IDs which reinforce each other's lies and spin) and a few trapped bulls (whose presence is also multiplied via other fake IDs) sing its "cake tomorrow" promises to the sky, and mentally-ill posters like 'Timbo_Slice' (+ at least six fake IDs to bolster his own non-existent credibility), who lacks any religious grounding, has fallen head over heels into this malicious cult. :D

You want proof? Sure. The company was incorporated nearly THIRTY YEARS AGO but has NEVER RETURNED A PROFIT TO INVESTORS! NEVER!! Just imagine, no dividends, EVER! Which is why the directors collectively hold only a token number of shares.

Need any more proof? You are certainly far too thick to be in the stockmarket at all - or, at least, anywhere outside FTSE, But I will humour you nonetheless.

"CANARIES" (Apparently, reading the main ramper, that is the latent business opportunity most relevant to EDEN.L) !

No, seriously. Scroll up and sample the posts of 'supersonico', IQ about 75, who exhibits the typical traits of an ""investor"" in dogsh!te. No research no reasoning just blind faith and belief, ignorance and subscription to all manner of idiotic unscientific conspiracy theories (Elvis still tangoes with the Yeti, 9/11 was an Inside Job and there are CANARIES everywhere, Naturally Covid never happened and all vaxes were conspiracies to alter human DNA, still more Canaries, etc ad nauseam), and, like the village idiot 'Timbo_Slice', convinces himself he is much smarter than the market and the share price :D

You won't need to sample many 'supersonico' postings to realise it is a LUNATIC. Whether it was mad in order to buy into a company whose main product IMO is rainbow-like RNSs and endless promises of cake tomorrow, decade after decade, or whether holding and justifying the holding of this excremental (they think that' a mix of incremental and exponential, ROTFL!) stock has made her crazy, I do not know. Probably a bit of both - but honestly it really doesn't matter. This is a stock for the EXTREMELY STUPID.

Walk away, there are good biotechs out there. This one is headed for a prepack (and ZERO PENCE for the ordinary holders) when the supply of USEFUL IDIOTS runs out.

END OF FACTUAL BULLETIN.... If reading this you still park your money here, I sincerely hope you meet as miserable an end as Timbo_Slice....

neutralpov
08/4/2024
07:26
Canary told you so.. now TalkTV tell you so..4 years too late.

“Pfizer LIED About Covid-19 Jabs” | Watchdog Accuses Pfizer Of Promoting 'Unlicensed Vaccine'

The UK's pharmaceutical watchdog has accused Pfizer of damaging the industry's reputation by using social media to promote an "unlicensed" Covid vaccine.

Pfizer has breached the regulatory code five times, including making misleading claims, failing to uphold high standards, and promoting unlicensed medicines.

The ruling by the Prescription Medicines Code of Practice Authority (PMCPA) follows a complaint about a message posted on social media in November 2020 by senior Pfizer employees.

The complaint raised concerns about Pfizer's improper use of social media to promote their Covid vaccine in violation of regulations.

This behavior was found to be more widespread than initially believed and extended to the highest levels of Pfizer's UK operation.

Dr David Bull and Dr Renee Hoenderkamp speak with doctor and Professor of oncology Angus Dalgleish.

supersonico
07/4/2024
08:51
Canary told you so...and now The Telegraph 4 years too late.

Pfizer found guilty of ‘bringing discredit’ on pharmaceutical industry after Covid social media posts
Watchdog rules company breached regulatory code five times including promoting unlicensed medicines
Camilla Turner, SUNDAY POLITICAL EDITOR6 April 2024 • 4:55pm
Pfizer has been accused by the UK’s pharmaceutical watchdog of “bringing discredit” on the industry after senior executives used social media to promote an “unlicensed” Covid vaccine.
The company has been found to have breached the regulatory code five times, which also includes making misleading claims, failing to maintain high standards and promoting unlicensed medicines.
A ruling by the pharmaceutical watchdog, the Prescription Medicines Code of Practice Authority (PMCPA), relates to a complaint about a message posted on X, formerly known as Twitter, in November 2020 by senior Pfizer employees.
The complaint raised concern about Pfizer’s “misuse of social media to misleadingly and illegally promote their Covid vaccine”, according to the ruling.
They claimed that such “misbehaviour” on social media was “even more widespread” than they had thought and “extended right to the top of their UK operation”.
‘UNLICENSED MEDICINE PROACTIVELY DISSEMINATED’
The complaint centred on a social media post on X by Dr Berkeley Phillips, the medical director of Pfizer UK. He shared a post from an employee of Pfizer in the US which said: “Our vaccine candidate is 95 per cent effective in preventing Covid-19, and 94 per cent effective in people over 65 years old. We will file all of our data with health authorities within days. Thank you to every volunteer in our trial, and to all who are tirelessly fighting this pandemic.”
Four other Pfizer employees, including one “senior” colleague, published the same message
The PMCPA ruling noted that this message contained “limited” information about the vaccine’s efficacy, no safety information and no reference to adverse events.
It went on to say that the social media post resulted in an “unlicensed medicine being proactively disseminated on Twitter to health professions and members of the public in the UK”.
A Pfizer UK spokesman said that the company “fully recognises and accepts the issues highlighted by this PMCPA ruling”, adding that it is “deeply sorry”.
They said: “Pfizer UK has a comprehensive policy on personal use of social media in relation to Pfizer’s business which prohibits colleagues from interacting with any social media related to Pfizer’s medicines and vaccines – backed by staff briefings and training.
“The personal use of social media by UK pharmaceutical industry employees in relation to company business is a challenging area for pharmaceutical companies, in which we continue to take all of the appropriate steps that are reasonably expected of a pharmaceutical company.”
As part of their response to the ruling, Pfizer said it had launched a review into its employees’ use of social media platforms to ensure compliance with their own rules as well as the regulatory code.
‘ACCIDENTAL AND UNINTENTIONAL’
It is the sixth time Pfizer has been reprimanded by the regulator over its promotion of the Covid-19 vaccine.
One ruling by the watchdog, from November 2022, found that Pfizer’s chief executive made “misleading” statements about children’s vaccines.
Following a complaint from the campaign group UsForThem, the PMCPA found that Pfizer had misled the public, made unsubstantiated claims and failed to present information in a balanced way.
Three of the other Pfizer cases related to LinkedIn posts, one related one was about claims made in a press release and one was about posts on X.
For the most recent series of breaches, Pfizer was charged administrative costs of £34,800.
Ben Kingsley, the head of legal affairs at UsForThem, said: “It’s astonishing how many times Pfizer’s senior executives have been found guilty of serious regulatory offences – in this case including the most serious offence of all under the UK Code of Practice.
“Yet the consequences for Pfizer and the individuals concerned continue to be derisory. This hopeless system of regulation for a multi-billion dollar life and death industry has become a sham, in dire need of reform.”
Dr Phillips, the UK country medical director for Pfizer, said the social media post was “accidental and unintentional” adding: “That said, we immediately accepted the case ruling and do everything we can to ensure that our employees adhere to our strict social media policy and the industry Code of Practice when using their personal social media.”
David Watson of the Association of the British Pharmaceutical Industry (ABPI) said that the code of practice, which is overseen by the PMCPA, sets “high standards for companies that reflect and go beyond UK law”.
He added that cases that are found to have brought discredit on the industry are advertised in the medical, pharmaceutical, and nursing press.

supersonico
Chat Pages: 717  716  715  714  713  712  711  710  709  708  707  706  Older

Your Recent History

Delayed Upgrade Clock